Back
Emergent BioSolutions Vs. Abbott Laboratories Industry Stock Comparison
Sell
44
EBS
Emergent BioSolutions
Last Price:
9.48
Seasonality Move:
13.84%
Buy
62
ABT
Abbott Laboratories
Last Price:
117.72
Seasonality Move:
2.69%
Sell
44
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $9.40. The Score for EBS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Abbott Laboratories (ABT)
is a Buy
Is Abbott Laboratories a Buy, Sell or Hold?
- The current Abbott Laboratories [ABT] share price is $117.26. The Score for ABT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ABT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $9.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing slight buying pressure.
ABT Stock Price Chart
What is Abbott Laboratories's stock price today?
-
The Abbott Laboratories share price today is $117.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.73 | Buy |
| Chaikin Money Flow: | 255537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.49 - 10.47) | Sell |
| Bollinger Bands (100): | (7.36 - 11.04) | Buy |
ABT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 54.44 | Buy |
| Chaikin Money Flow: | 3854607 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.73 - 117.73) | Buy |
| Bollinger Bands (100): | (107.08 - 116.94) | Buy |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.13 | Buy |
| 20-day SMA: | 9.52 | Sell |
| 50-day SMA: | 8.72 | Buy |
| 200-day SMA: | 6.43 | Buy |
| 8-day EMA: | 9.16 | Buy |
| 20-day EMA: | 9.33 | Buy |
| 50-day EMA: | 9.06 | Buy |
| 200-day EMA: | 7.46 | Buy |
ABT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 116.35 | Buy |
| 20-day SMA: | 115.99 | Buy |
| 50-day SMA: | 115.53 | Buy |
| 200-day SMA: | 110.78 | Buy |
| 8-day EMA: | 116.55 | Buy |
| 20-day EMA: | 116.24 | Buy |
| 50-day EMA: | 115.12 | Buy |
| 200-day EMA: | 110.97 | Buy |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.87 per share, and an increase next year of $3.99 per share.
Abbott Laboratories Earnings Growth & ABT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.48 per share.
Emergent BioSolutions Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Abbott Laboratories Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||